As pharmaceutical companies look increasingly towards biological macromolecules like antibodies as new drugs, there is a rapidly growing need to be able to characterize these complex ‘drug candidates’ in detail. Rapid Novor, an international leader in antibody sequencing and characterization services, and the Wilson group, an academic leader in the development of HDX technologies, have […]
Read More